SOLV Stock Analysis: Buy, Sell, or Hold?
SOLV - Solventum Corporation
$73.45
-0.11 (-0.15%)
▼
5d:
-4.49%
30d:
-4.3%
90d:
+11.81%
BUY
HIGH Confidence
Analysis Updated: Jun 22, 2026 12:00 AM ET
Earnings: Aug 06, 2026
Get Alerted When SOLV Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: SOLV shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
✅ BUY SIGNAL: SOLV shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$103.41
Based on 5.8% avg growth
INTRINSIC VALUE TODAY
$64.21
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 11.1x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: SOLV is currently trading at $73.45, which is considered oversold relative to its 30-day fair value range of $74.63 to $79.50. The stock's valuation (Forward PE: 10.4) is in line with its historical norms (11.1). Remarkably, the market is currently pricing in an annual earnings decline of 2.1% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, SOLV is showing sideways momentum. The price is currently testing key support at $73.31. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $82.15 (+11.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, SOLV is showing sideways momentum. The price is currently testing key support at $73.31. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $82.15 (+11.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$74.63 -
$79.50
Company Quality Score
49/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
77.1%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($82.15)
Trading Range Analysis
30-Day Trading Range
$74.63 -
$79.50
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$73.31
Resistance Level
$82.72
Current Trend
Sideways
Technical data as of
Jun 22, 2026
Fundamental Context
Forward P/E (Next Year Est.)
10.44
Wall Street Target
$82.15
(+11.7%)
Revenue Growth (YoY)
-3.0%
Earnings Growth (YoY)
-91.0%
Profit Margin
17.3%
Valuation Discount vs History
-2.1% cheaper
PE vs Historical
10.4 vs 11.1
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-2.1%
(market-implied from PE analysis)
1-Year Target
$72.02
(-2%)
2-Year Target
$70.50
(-4%)
3-Year Target
$69.02
(-6%)
3-Yr Target (if PE normalizes)
(PE: 10→11)
$73.39
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: 7.5%)
$190.81
(+159%)
Base:
(SPY PE: 10.4, Growth: 7.5%)
$91.46
(+24%)
Bear:
(PE: 8.9, Growth: 7.5%)
$77.74
(+6%)
📈
Valuation based on Current Earnings
Trailing PE: 9.23 | Current EPS (TTM): $8.17
Bull Case
$71.56
(-3%)
Analyst growth -13.8%, PE expands to 10.2
Base Case
$65.06
(-12%)
Market implied -13.8%, PE stable at 9.2
Bear Case
$51.29
(-30%)
Severe decline -20.0%, PE contracts to 7.9
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 10.4 to 11.1
Stabilization Target:
$78.22
(+6.3%)
PE Expansion Potential:
+6.3%
Share & Embed Analysis
Last updated: June 23, 2026 12:59 PM ET
Data refreshes hourly during market hours. Next update: 1:59 PM
Data refreshes hourly during market hours. Next update: 1:59 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SOLV showing a specific setup today?
Insider Activity (6 Months)
1
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Amy Mcbride Wendell
BUY
1475 shares
2026-03-10
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ISRG
Intuitive Surgical Inc |
BUY
33 analysts |
$565 | 58 HOLD |
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$88 | 55 HOLD |
|
RGEN
Repligen Corporation |
STRONG BUY
19 analysts |
$176 | 55 HOLD |
|
WST
West Pharmaceutical Serv… |
STRONG BUY
13 analysts |
$359 | 64 BUY |
|
RMD
ResMed Inc |
BUY
19 analysts |
$262 | 62 BUY |
Advanced SOLV Option Strategies
Professional options setups generated by AI based on today's SOLV price and gamma walls.
